NCT04107168 2023-02-16Microbiome Immunotherapy Toxicity and Response EvaluationCambridge University Hospitals NHS Foundation TrustUnknown1,800 enrolled
NCT04860076 2021-04-26Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid TumorsAsylia Diagnostics BVUnknown400 enrolled
NCT04136470 2020-08-10BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and DiagnosticsArdigenUnknown130 enrolled
NCT04145232 2020-08-10AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.ArdigenUnknown30 enrolled